연구성과로 돌아가기
2020 연구성과별 연구자 정보 (398 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Comparison of the intraoperative analgesic efficacy between ultrasound-guided deep and superficial serratus anterior plane block during video-assisted thoracoscopic lobectomy A prospective randomized clinical trial | Kim, Jeongeun | Kim, J | 4 | Yeungnam Univ, Dept Anesthesiol & Pain Med, Coll Med, Daegu, South Korea | saeyoungkim7@gmail.com; | |||||
| Comparison of the intraoperative analgesic efficacy between ultrasound-guided deep and superficial serratus anterior plane block during video-assisted thoracoscopic lobectomy A prospective randomized clinical trial | Kim, Jiseob | Kim, J | 5 | Keimyung Univ, Dept Anesthesiol & Pain Med, Sch Med, Daegu, South Korea | 0000-0002-8273-8644 | gim, jiseob | saeyoungkim7@gmail.com; | |||
| Comparison of the intraoperative analgesic efficacy between ultrasound-guided deep and superficial serratus anterior plane block during video-assisted thoracoscopic lobectomy A prospective randomized clinical trial | Kim, Saeyoung | Kim, S | 6 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, 130 Dongdeok Ro, Daegu 41944, South Korea | saeyoungkim7@gmail.com; | ||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Lee, In Hee | Lee, IH | 1 | Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Oncol Hematol, Daegu, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Lee, In Hee | Lee, IH | 1 | Daegu Catholic Univ, Dept Internal Med, Div Hematol Oncol, Sch Med, Daegu, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Kang, Byung Woog | Kang, BW | 2 | 교신저자 | Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Oncol Hematol, Daegu, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | ||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Kim, Jong Gwang | Kim, JG | 3 | Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Oncol Hematol, Daegu, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Bae, Woo Kyun | Bae, WK | 4 | Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Ki, Myung Seo | Ki, MS | 5 | Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Park, Inkeun | Park, I | 6 | 교신저자 | Gachon Univ, Dept Internal Med, Div Med Oncol, Gil Med Ctr, 21 Namdong Daero 774beon Gil, Incheon 21565, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | ||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Jo, Jae-Cheol | Jo, JC | 7 | Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan, South Korea | CAE-9453-2022 | Jo, Jae-Cheol | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Kim, Jin Young | Kim, JY | 8 | Keimyung Univ, Dept Internal Med, Div Hematol Oncol, Dongsan Med Ctr, Daegu, South Korea | V-9262-2017 | Kim, Kyu-Sik | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Koh, Sung Ae | Koh, SA | 9 | Yeungnam Univ, Dept Hematol Oncol, Coll Med, Daegu, South Korea | JXL-8219-2024 | Kim, Sung-Bae | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Lee, Kyung Hee | Lee, KH | 10 | Yeungnam Univ, Dept Hematol Oncol, Coll Med, Daegu, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; | |||||
| Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy | Cho, Yoon Young | Cho, YY | 11 | Daegu Catholic Univ, Dept Hematol Oncol, Med Ctr, Daegu, South Korea | bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; |
페이지 이동: